GARENOXACIN

GARENOXACIN Suppliers list
Company Name: SEUTIC  
Tel: +91-8309787199
Email: sales@seutic.com
Products Intro: Product Name:1-Cyclopropyl-8-(difluoromethoxy)-7-(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
CAS:194804-72-3
Purity:99% Package:1 kg,5 kg, 10 kg,25kg and 1 MT
Company Name: Hubei Xinyang Medical Technology Co., Ltd  
Tel: 15347293736
Email: 2853117764@qq.com
Products Intro: Product Name:GARENOXACIN
CAS:194804-72-3
Purity:99% HPLC Package:10mg;25mg;50mg;100mg;200mg;500mg
GARENOXACIN Basic information
Product Name:GARENOXACIN
Synonyms:1-Cyclopropyl-8-(difluoromethoxy)-7-(1-methylisoindolin-5-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-(2,3-dihydro-1-methyl-1H-isoindol-5-yl)-1,4-dihydro-4-oxo-
CAS:194804-72-3
MF:C23H20F2N2O4
MW:426.41
EINECS:
Product Categories:
Mol File:194804-72-3.mol
GARENOXACIN Structure
GARENOXACIN Chemical Properties
Melting point 234-235 °C
Boiling point 581.5±50.0 °C(Predicted)
density 1.421±0.06 g/cm3(Predicted)
pka6.44±0.50(Predicted)
Safety Information
MSDS Information
GARENOXACIN Usage And Synthesis
GARENOXACIN Preparation Products And Raw materials
Tag:GARENOXACIN(194804-72-3) Related Product Information
C-(2'-METHOXY-BIPHENYL-4-YL)-METHYLAMINE HYDROCHLORIDE Garenoxacin GARENOXACIN MESYLATE [1,1'-BIPHENYL]-4-CARBOXALDEHYDE,2-METHOXY- GARENOXACIN

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.